WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005123908) NOVEL CANCER CELL LINES AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/123908    International Application No.:    PCT/US2005/020137
Publication Date: 29.12.2005 International Filing Date: 08.06.2005
IPC:
C12N 5/06 (2006.01), A61K 39/00 (2006.01)
Applicants: DAUGHTERS OF CHARITY HEALTH SYSTEM EXTRAORDINARY [US/US]; 26000 Altamont Road, Los Altos Hills, CA 94022-4317 (US) (For All Designated States Except US).
WISEMAN, Charles [US/US]; (US) (For US Only).
KHARAZI, Alex [US/US]; (US) (For US Only)
Inventors: WISEMAN, Charles; (US).
KHARAZI, Alex; (US)
Agent: PEREZ DE LA CRUZ, Ignacio; Fish & Neave IP Group of Ropes & Gray LLP, One International Place, Boston, MA 02110-2624 (US)
Priority Data:
10/868,094 14.06.2004 US
Title (EN) NOVEL CANCER CELL LINES AND USES THEREOF
(FR) NOUVELLES LIGNEES CELLULAIRES CANCEREUSES ET LEURS UTILISATIONS
Abstract: front page image
(EN)The invention provides, in part, novel SV-BR cancer cell lines. The invention provides a novel cell line SV-BR-1 deposited under ATCC ___, and SV-BR-1-GM cells deposited under ATCC ___. The invention further relates to therapeutic and non-therapeutic uses of the novel cell lines, and to use of the cell lines in the manufacture of medicaments for inducing immune responses and/or for treating tumors and cancers. Therapeutic uses include the use of SV-BR cell lines as cancer vaccines, and in particular, or the treatment of cancer.
(FR)L'invention concerne, en partie, de nouvelles lignées cellulaires cancéreuses SV-BR. Elle concerne une nouvelle lignée cellulaire cancéreuse SV-BR-1 déposée sous ATCC___, et des cellules SV-BR-1GM déposées sous ATCC___. L'invention concerne en outre des utilisations thérapeutiques et non thérapeutiques de ces nouvelles lignées cellulaires, ainsi que l'utilisation de ces lignées cellulaires dans la fabrication de médicaments destinés à induire des réponses immunes et/ou au traitement de tumeurs et cancers. Les utilisations thérapeutiques concernent notamment l'utilisation de lignées cellulaires SV-BR comme vaccins contre les cancers et, en particulier, dans le traitement du cancer.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)